• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子从矿化聚(丙交酯-共-乙交酯)支架中持续释放用于组织工程。

Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.

作者信息

Murphy W L, Peters M C, Kohn D H, Mooney D J

机构信息

Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109-2136, USA.

出版信息

Biomaterials. 2000 Dec;21(24):2521-7. doi: 10.1016/s0142-9612(00)00120-4.

DOI:10.1016/s0142-9612(00)00120-4
PMID:11071602
Abstract

Strategies to engineer bone tissue have focused on either: (1) the use of scaffolds for osteogenic cell transplantation or as conductive substrates for guided bone regeneration; or (2) release of inductive bioactive factors from these scaffold materials. This study describes an approach to add an inductive component to an osteoconductive scaffold for bone tissue engineering. We report the release of bioactive vascular endothelial growth factor (VEGF) from a mineralized, porous, degradable polymer scaffold. Three dimensional, porous scaffolds of the copolymer 85 : 15 poly(lactide-co-glycolide) were fabricated by including the growth factor into a gas foaming/particulate leaching process. The scaffold was then mineralized via incubation in a simulated body fluid. Growth of a bone-like mineral film on the inner pore surfaces of the porous scaffold is confirmed by mass increase measurements and quantification of phosphate content within scaffolds. Release of 125I-labeled VEGF was tracked over a 15 day period to determine release kinetics from the mineralized scaffolds. Sustained release from the mineralized scaffolds was achieved, and growth of the mineral film had only a minor effect on the release kinetics from the scaffolds. The VEGF released from the mineralized and non-mineralized scaffolds was over 70% active for up to 12 days following mineralization treatment, and the growth of mineral had little effect on total scaffold porosity.

摘要

构建骨组织的策略主要集中在以下两个方面

(1)使用支架进行成骨细胞移植,或作为引导骨再生的传导性基质;(2)从这些支架材料中释放诱导性生物活性因子。本研究描述了一种在骨组织工程的骨传导支架中添加诱导成分的方法。我们报道了生物活性血管内皮生长因子(VEGF)从一种矿化、多孔、可降解的聚合物支架中的释放情况。通过将生长因子纳入气体发泡/颗粒沥滤过程,制备了共聚物85:15聚(丙交酯-共-乙交酯)的三维多孔支架。然后将该支架在模拟体液中孵育使其矿化。通过质量增加测量和支架内磷酸盐含量的定量分析,证实了多孔支架内孔表面有类骨矿物质膜的生长。在15天的时间内追踪125I标记的VEGF的释放情况,以确定矿化支架的释放动力学。实现了从矿化支架的持续释放,并且矿物质膜的生长对支架的释放动力学仅有轻微影响。矿化和未矿化支架释放的VEGF在矿化处理后的12天内活性超过70%,并且矿物质的生长对支架的总孔隙率影响很小。

相似文献

1
Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering.血管内皮生长因子从矿化聚(丙交酯-共-乙交酯)支架中持续释放用于组织工程。
Biomaterials. 2000 Dec;21(24):2521-7. doi: 10.1016/s0142-9612(00)00120-4.
2
Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro.多孔聚(丙交酯-乙交酯)支架内连续骨样矿物质在体外的生长
J Biomed Mater Res. 2000 Apr;50(1):50-8. doi: 10.1002/(sici)1097-4636(200004)50:1<50::aid-jbm8>3.0.co;2-f.
3
Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells.使用间充质干细胞从多孔聚乳酸-羟基乙酸共聚物支架中持续释放抗坏血酸-2-磷酸酯和地塞米松用于骨组织工程
Biomaterials. 2003 Nov;24(25):4671-9. doi: 10.1016/s0142-9612(03)00358-2.
4
Bone regeneration via a mineral substrate and induced angiogenesis.通过矿物质底物实现骨再生并诱导血管生成。
J Dent Res. 2004 Mar;83(3):204-10. doi: 10.1177/154405910408300304.
5
VEGF-incorporated biomimetic poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering.用于骨组织工程的 VEGF 结合仿生聚(丙交酯-乙交酯)烧结微球支架。
J Biomed Mater Res B Appl Biomater. 2012 Nov;100(8):2187-96. doi: 10.1002/jbm.b.32787. Epub 2012 Aug 22.
6
Pretreatment of poly(l-lactide-co-glycolide) scaffolds with sodium hydroxide enhances osteoblastic differentiation and slows proliferation of mouse preosteoblast cells.用氢氧化钠对聚(L-丙交酯-共-乙交酯)支架进行预处理可增强小鼠前成骨细胞的成骨细胞分化并减缓其增殖。
Plast Reconstr Surg. 2008 Feb;121(2):424-434. doi: 10.1097/01.prs.0000298366.74273.da.
7
The construction and investigation of PLGA artificial bone by biomimetic mineralization.聚乳酸-羟基乙酸共聚物人工骨的仿生矿化构建与研究
J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):687-9. doi: 10.1007/BF02896171.
8
Mineralized poly(lactic acid) scaffolds loading vascular endothelial growth factor and the in vivo performance in rat subcutaneous model.载有血管内皮生长因子的矿化聚乳酸支架及其在大鼠皮下模型中的体内性能。
J Biomed Mater Res A. 2013 May;101(5):1447-55. doi: 10.1002/jbm.a.34446. Epub 2012 Oct 31.
9
Effects of VEGF loading on scaffold-confined vascularization.载有 VEGF 的支架对血管化的限制作用。
J Biomed Mater Res A. 2010 Dec 1;95(3):783-92. doi: 10.1002/jbm.a.32902.
10
Temporally regulated delivery of VEGF in vitro and in vivo.血管内皮生长因子(VEGF)在体外和体内的时间调控递送。
J Biomed Mater Res A. 2006 Oct;79(1):176-84. doi: 10.1002/jbm.a.30771.

引用本文的文献

1
Strategies for the vascular patterning of engineered tissues for organ repair.用于器官修复的工程组织血管图案化策略。
Nat Biomed Eng. 2025 Jun 20. doi: 10.1038/s41551-025-01420-w.
2
Bioprinted platform for parallelized screening of engineered microtissues in vivo.用于体内工程化微组织并行筛选的生物打印平台。
Cell Stem Cell. 2025 May 1;32(5):838-853.e6. doi: 10.1016/j.stem.2025.03.002. Epub 2025 Mar 31.
3
Customized Heparinized Alginate and Collagen Hydrogels for Tunable, Local Delivery of Angiogenic Proteins.定制肝素化藻酸盐和胶原蛋白水凝胶用于血管生成蛋白的可调谐局部递送。
ACS Biomater Sci Eng. 2025 Mar 10;11(3):1612-1628. doi: 10.1021/acsbiomaterials.4c01823. Epub 2025 Feb 13.
4
Integrating Micro- and Nanostructured Platforms and Biological Drugs to Enhance Biomaterial-Based Bone Regeneration Strategies.整合微纳结构平台与生物药物以增强基于生物材料的骨再生策略
Biomacromolecules. 2025 Jan 13;26(1):140-162. doi: 10.1021/acs.biomac.4c01133. Epub 2024 Dec 2.
5
Bone Tissue Engineering and Nanotechnology: A Promising Combination for Bone Regeneration.骨组织工程与纳米技术:骨再生的一种有前景的组合。
Biology (Basel). 2024 Apr 2;13(4):237. doi: 10.3390/biology13040237.
6
Protein-modified nanomaterials: emerging trends in skin wound healing.蛋白质修饰的纳米材料:皮肤伤口愈合的新趋势
Discov Nano. 2023 Oct 16;18(1):127. doi: 10.1186/s11671-023-03903-8.
7
Current Concepts and Methods in Tissue Interface Scaffold Fabrication.组织界面支架制造的当前概念与方法
Biomimetics (Basel). 2022 Oct 4;7(4):151. doi: 10.3390/biomimetics7040151.
8
Engineering the multiscale complexity of vascular networks.构建血管网络的多尺度复杂性。
Nat Rev Mater. 2022;7(9):702-716. doi: 10.1038/s41578-022-00447-8. Epub 2022 May 31.
9
A 'Relay'-Type Drug-Eluting Nerve Guide Conduit: Computational Fluid Dynamics Modeling of the Drug Eluting Efficiency of Various Drug Release Systems.一种“接力”式药物洗脱神经导管:各种药物释放系统药物洗脱效率的计算流体动力学建模
Pharmaceutics. 2022 Jan 19;14(2):230. doi: 10.3390/pharmaceutics14020230.
10
Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw.局部递送水凝胶包封的血管内皮生长因子预防药物相关性颌骨坏死。
Sci Rep. 2021 Dec 3;11(1):23371. doi: 10.1038/s41598-021-02637-w.